Premium
Private equity firm The Carlyle Group is evaluating a Hyderabad-based bulk-drugs maker as part of its plan to build an investment......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
